Pharmacological effects of Sotorasib

Sotorasib (Sotorasib) is a targeted tumor treatment drug that is a RAS mutation inhibitor. Its pharmacological effects are mainly focused on the inhibition of RAS protein, and RAS gene mutations play a key role in a variety of cancers, especially pancreatic cancer, colorectal cancer, and lung cancer.

RAS is a group of proteins involved in cell signaling, regulating cell growth and differentiation in normal cells. However, when the RAS gene is mutated, these proteins may lose their normal regulatory functions, leading to abnormal cell proliferation and the occurrence of cancer. The main function of sotoracib is to interfere with the abnormal signaling of cancer cells by specifically inhibiting the mutated RAS protein, thereby inhibiting the growth and spread of cancer cells.

Specifically, sotorasiib blocks the active site of RAS by binding to RAS protein, making it unable to effectively participate in cell signaling pathways. This inhibitory effect helps slow down the proliferation rate of cancer cells and promotes apoptosis (programmed death) of these abnormal cells, thereby blocking tumor progression.

The unique nature of this pharmacological action makes sotorasiib a targeted therapy for RAS mutations, providing a new treatment option for patients suffering from RAS mutant cancers. However, it should be noted that the use of sotoraxib may still be associated with some side effects, so patients should receive detailed consultation and monitoring from their doctor before use.

The original drug of sotorasibu has not yet been launched in China, so patients cannot purchase it domestically and need to purchase sotorasibu through overseas channels. The price of the original version of sotorasibu in Hong Kong, China, with the specifications of 120mg*240 tablets, is around 8 million, and the price of the European version of the original drug with the same specifications is around 4 million, which is relatively expensive. The cheaper ones are the generic drugs marketed abroad. For example, the price of generic drugs in Laos and Bangladesh is around two to three thousand yuan. The price is relatively cheap, and the ingredients of foreign generic drugs are basically the same as the original drugs.